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Summary. Androgenic steroids regulate the 
development and size of mammalian prostate epithelial 
cells. To evaluate the relationship between Fas-Fas 
ligand system and apoptosis in prostate epithelial cells of 
the castrated rats, we have examined immunocyto- 
chemical localization of Fas antigen in the castrated rat 
prostate glands at a series of different times. We used a 
rabbit polyclonal anti-Fas antibody with a streptavidin- 
biotin method and confocal laser scanning method or an 
immunogold method. Fas immunolocalization was 
exarnined in ventral lobes of prostate glands taken from 
intact or castrated adult male Wistar rats on day 1 ,2 ,3 ,4  
and 5 by light or electron microscopy. At a light 
microscopic level, the castrated prostate epithelial cells 
showed mostly Fas immunolocalization in their apical 
parts of cytoplasm on day 2 after the castration. In 
addition, their extent of the Fas expression was 
expanded throughout the cytoplasm in proportion to the 
androgen ablation periods, and later the Fas expression 
was detected at luminar or basolateral sides of the 
epithelial cells. Both immunogold labeling with ultrathin 
sections and immunoperoxidase technique with cryostat 
sections demonstrated that Fas was localized mainly in 
secretory granules of the castrated prostate epithelial 
cells and some parts of their cell membranes at later 
stages. Our immunocytochemical findings showed that 
Fas expression was time-dependently induced in most of 
the prostatic epithelial cells after castration of rats. The 
rate of Fas-expressing epithelial cells was too high and 
inconsistent with the previously reported rate of 
TUNEL-positive ones. The membrane-associated Fas 
may have little effect on the apoptosis in the present 
case, bacause a lot of soluble Fas was secreted from the 
prostatic epithelial cells. A further study is needed to 
clarify some significance of the secretory Fas in the 
prostatic epithelium after the rat castration. 
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lntroduction 
It has been well-known that postpuberal 
development of rat prostate glands depends upon 
sufficient amounts of circulating androgen hormone 
(Isaacs, 1984; Kyprianou and Isaacs, 1998), and that the 
androgen ablation causes a rapid atrophy of epithelium 
in their ventral lobe (Sanford et al., 1984; Banerjee et al., 
1995). Morphologically, the androgen ablation with rat 
castration reduces the epithelial cell height and the 
number of apical vesicles in cytoplasm, and finally 
induces a typical apoptosis of the epithelial ceils (Isaacs 
et al., 1984; Sanford et al., 1984; Banerjee et al., 1995; 
Kyprianou and Isaacs, 1998). The apoptosis is different 
from necrosis in respect to morphological changes and 
cell death processes. The apoptotic cells usually show an 
aggregation of nuclear chromatin near nuclear envelopes 
and its rapid condensation in their cytoplasm. Other 
morphological features are cytoplasmic aggregation 
without alteration of cell organelle integrity and then 
final fragmentation into apoptotic bodies (Kerr et al., 
1972; Gaffney et al., 1995; Julliard et al., 1996). Recent 
extensive studies on apoptosis have already disclosed 
such molecular mechanisms that play an important role 
in the homeostasis of multicellular organisms, genetic 
regulation, immune system mechanism including 
autoimmune diseases, and cancers (Cummings et al., 
1997; Leach, 1998; Schmitt and Lowe, 1999). 
In addition, various apoptotic death signals have 
been recently identified to initiate apoptosis in animal 
cells (Nagata and Golstein, 1995). The Fas is a type 1 
membrane protein of 45 kDa which belongs to the tumor 
necrosis factor(TNF)/nerve growth factor receptor 
family. Functionally, it is a cell surface receptor that is 
capable of initiating an apoptotic signaling pathway 
when bound to Fas ligand (Itoh et al., 1991; Oehm et al., 
1992; Suda et al., 1993). In animal bodies, it is usually 
expressed in cytotoxic T cells, B celis, and several other 
cells in livers, hearts, kidneys, ovaries, and thymus 
(Oehm et al., 1992; Suda et al., 1993; Krammer et al., 
1994; Schmitt and Lowe, 1999). Additionally, Fas and 
Fas ligand have been found to be expressed in a few 
epithelial tissues, which are marked by the apoptotic ceil 
turnover, such as the prostate and uterus (Leithauser et 
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al., 1993; French et al., 1996; Xerri et al., 1997). Both of 
these tissues are steroid hormone-dependent and usually 
undergo apoptosis within 24-48h after the hormone 
depletion (Isaacs, 1984; Rotello et al., 1992). 
Interestingly, the apoptosis that occurres in response to 
the steroid hormone depletion has been recently shown 
to require sufficient Fas expression in epithelial cells 
(Suzuki et al., 1996). These data support a role for the 
Fas signaling pathway in the normal renewal of the 
prostate and uterine epithelium. In humans, at least five 
Fas isoforms can be generated by alternative splicing of 
a Fas gene, and four of them lack transmembrane 
domains, resulting in soluble forms (Cheng et al., 1994; 
Owen-Schaub et al., 1995). Some in vitro studies have 
suggested that the soluble Fas inhibits cell death through 
the previous binding with Fas ligand in the extracellular 
matrix (Cheng et a1.,1994; Owen-Schaub et al, 1995). 
Severa1 tumor cell lines themselves synthesize the 
soluble Fas and may be protected from the immune 
reaction system (Lee et al., 1998). Recently, the 
existence of soluble Fas was also reported in rats 
(Kobayashi and Koike, 1996). 
It has been assumed that the Fas-Fas ligand system 
may play an important role in mediating apoptosis of 
prostate glands after castration (Isaacs et al., 1992). 
Some previous studies reported that apoptosis occurred 
in the prostate epithelium of mice following their 
castration, and that Fas upregulation has also been 
detected in the castrated prostate (Lee et al., 1998). Our 
previous study demonstrated that Fas upregulation has 
been detected under various concentrations of 
testosterone in cultured prostatic epithelial cells of rats 
(Furuya et al., 2000). However, there has been no report 
as to immunolocalization of Fas in the prostate 
epithelium of castrated rats at an electron microscopic 
level. In the present study, to address whether castration 
induces the apoptosis of prostate epithelial cells through 
the Fas-Fas ligand system, we have examined 
immunocytochemically the Fas expression in the 
castrated rat prostate glands at a series of different times. 
Materials and niethods 
Animals and tissue preparations 
A total of 30 adult male Wistar rats at ages of 11-15 
weeks were housed in an air-conditioned room with food 
and water ad libitum. Some rats were castrated under 
intraperitoneal anesthesia with sodium pentobarbital 
(10mgIkg body weight), and used for the present 
experiment on day 1, 2, 3, 4, and 5, as described before 
(Kubo et al., 1998). Anesthetized rats with the sodium 
pentobarbital after weighing the bodies were perfused 
with 2% paraformaldehyde (PF) or 2% PF mixed with 
0.05% glutaraldehyde (GL) in 0.1M phosphate buffer 
(PB), pH7.4, via left cardiac ventricles. Ventral lobes of 
prostates were isolated under observation with a 
dissection microscope, and additionally fixed in the 
same fixative for lh.  Animal experimental protocols 
were approved by the Animal Use Committee of 
Yamanashi Medical University. 
Weight measurement of ventral lobes 
Isolated ventral lobes were blotted onto filter paper 
and their wet weights were checked, as reported before 
(Kubo et al., 1998). A relative weight of the ventral lobe 
to the body weight was calculated and expressed as a 
percentage. Means and standard deviations were 
obtained from 4 rats in each group (data not shown), 
indicating that they were almost similar to those as 
reported before (Kubo et al., 1998). 
Antibodies 
We used rabbit polyclonal anti-Fas antibody raised 
against a peptide corresponding to amino acids 295-314 
mapping at the carboxy terminus (X-20, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA), which was 
used at 1:1000 dilution. 
lmmunoperoxidase technique 
Prostatic tissues fixed with 2% PF were routinely 
dehydrated in a graded series of alcohol and embedded 
in Paraffin, cut at 4 pm thickness, and finally mounted 
on gelatin-coated glass slides. After being deparaffinized 
in a routine xylene-methanol series, the sections on the 
glass slides were treated with 0.3% hydrogen peroxide in 
methanol for 15 min and washed in PBS. They were 
then incubated with 10% normal goat serum for 30 min 
to block non-specific reactions, and with primary anti- 
Fas antibody in PBS containing 2% bovine serum 
albumin at 4 OC overnight. After being rinsed in PBS, 
they were incubated with biotin-labeled anti-rabbit IgG 
antibody for 10  min, and then with peroxidase- 
labeled streptavidin for 5 min according to the 
manufacture's protocol (Histofine, Nichirei, Tokyo, 
Japan). Subsequently the immunostained sections were 
treated with a metal-enhanced diaminobenzidine 
technique (Pierce, IL, USA) and methylgreen for 
counterstaining. 
Confocal laser scanning microscopy 
Paraffin sections at 4 pm thickness were treated with 
0.3% hydrogen peroxide in methanol for 15 min and 
washed in PBS. They were incubated with 10% normal 
goat serum for 30 min, the primary antibody at 4 OC 
overnight, and biotin-labeled anti-rabbit IgG antibody 
for 10 min. Subsequently, they were incubated with 
Alexa 488-labeled streptavidin (1:500, Molecular 
Probes, OR, USA) and propidium iodide at 1:1000 
dilution for lh .  After embedding with anti-fading 
mounting medium (Bio Rad Laboratories, CA, USA), 
they were routinely observed with a confocal laser 
scanning microscope (TCS4D: Leica, Heidelberg, 
Germany). 
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Conventional electron microscopy 
Some castrated or normal rats were perfused with 
2.5% GL in 0.1M PB via hearts. The prostate tissues 
were additionally immersed in the same fixative for lh, 
postfixed with 1% osmium tetroxide in 0.1M PB for lh, 
dehydrated in a graded series of ethanol and embedded 
in Quetol 812 (Nishin EM, Tokyo, Japan). Ultrathin 
sections at 75 nm thickness were cut with an 
ultramicrotome, counterstained with uranyl acetate and 
lead citrate, and finally examined in a Hitachi H-7500 
electron microscope (Hitachi, Tokyo, Japan) at an 
accelerating voltage of 80 kv. 
lmmunoe/ectron microscopy 
Pre-embedding immunostaining 
Under anesthesia with sodium pentobarbital, other 
castrated or normal rats were perfused with 2% 
paraformaldehyde (PF) in O.lM PB via the left cardiac 
ventricle. Aftenvards, the prostate ventral lobes were 
removed and pieces of the prostatic tissues were 
immersed in 30% sucrose, embedded in Tissue Tek 
(Miles Inc. IN, USA) and frozen in liquid nitrogen. 
Severa1 serial 4 pm sections were obtained from each 
sample and mounted on gelatin-coated glass slides. They 
were washed in PBS and treated with 0.3% hydrogen 
peroxide in methanol for 10 rnin. After being rinsed with 
PBS, they were incubated with 10% normal goat serum 
for 10 min to block non-specific antibody binding 
reactions. They were immunoreacted with the primary 
anti-Fas antibody (X-20) diluted at 1:500 in PBS 
containing 2% bovine serum albumin (BSA) at 4 OC for 
18h. After being rinsed with PBS, they were incubated 
in biotin-labeled anti-rabbit IgG antibody for 10 min. 
They were immersed in peroxidase-labeled streptavidin 
for 5 min. They were fixed with 0.25% GL in 0.1M PB 
for 15 min and reacted with metal-enhanced 
diaminobenzidine (Pierce, IL, USA) solution for 3 min. 
They were post-fixed with 1% osmium tetroxide in 0.1M 
PB for 60 min and dehydrated in a graded series of 
ethanol for a few minutes. They were embedded in 
Quetol 812 by an inverted gelatin capsule method. 
Ultrathin sections were cut with an ultramicrotome, 
mounted on copper grids and observed with an H-7500 
electron microscope at an accelerating voltage of 80kV 
Immunogold method 
Some anesthetized rats were perfused with 2% PF 
and 0.05% GL in 0.1M PB via hearts. Ventral lobes of 
their prostates were removed, cut into small pieces and 
immersed in the same fixative at 4 "C for 30 min. They 
were dehydrated in a graded series of dimethyl- 
formamide (DMFA, Kanto-Chemical Co., Tokyo, 
Japan), embedded in Lowicryl K4M (Polyscience, Inc, 
Washington, USA) and polymerized under ultraviolet 
light at -20 "C for 36h. Ultrathin sections at 80nm 
thickness were cut and mounted on Formvar-coated 
nickel grids. They were blocked with 2% BSA and 5% 
normal goat serum in PBS for 30 rnin and incubated with 
the primary anti-Fas antibody at 1:1000 dilution in PBS 
containing 2% BSA at 4 OC overnight. Subsequently, 
they were incubated with goat anti-rabbit IgG antibody 
conjugated with 10nm colloidal gold (1:40; British Bio 
Cell International, Cardiff, UK) at room temperature for 
lh. After being fixed with 2% GL in 0.1M PB for 10 
min, they were counter-stained only with uranyl acetate 
and coated with carbon. The immunostained sections 
were routinely observed with an H-7500 electron 
microscope. 
Results 
Light microscopic immunoperoxidase technique 
Immunohistochemical changes of prostates were 
found in apical sites of the epithelium at early stages in 
castrated rats (Fig. lb), as compared with those in 
normal rats (Fig. la). Immunoreaction products of Fas 
were recognized in granular patterns mainly at apical 
sites of the prostate epithelium and Golgi areas (Fig. lb, 
inset), and additionally localized in deep cytoplasm of 
the epithelial cells at later stages (Fig. lc). On day 2 
after the castration, Fas-immunopositive epithelial cells 
were found in more than half of the whole prostate 
epithelium (Fig. lb). Furthermore, the Fas-immuno- 
positive cells were spreading throughout the polarized 
epithelium on day 3. On day 4, many epithelial cells 
were positively immunostained not only in apical 
cytoplasmic parts, but also lateral and basal ones (Fig. 
lc). On the contrary, no immunopositive reaction was 
found in sections obtaind £rom uncastrated rats (Fig. la) 
and in immunocontrol sections (data not shown). 
Confocal laser scanning microscopy 
The similar immunocytochemical changes which 
were obtained by the immunoperoxidase technique for 
the prostates, were also found in apical sites of the 
epithelium on day 2 (Fig. Id). Immunoreaction products 
of Fas were recognized in granular pattems mainly at the 
apical cytoplasm and supranuclear regions of the 
prostate epithelium, and additionally localized on 
secretory vesicles in not only apical but also deep 
cytoplasm of the epithelial cells at later stages (Fig. le). 
Pre-embedding immunostaining 
At an electron microscopic level, the pre-embedding 
immunoperoxidase technique with cryostat sections 
demonstrated that Fas-immunoreactive products were 
localized mainly in vesicular stnictures along apical ceil 
membranes and Golgi areas in supranuclear cytoplasm 
of prostatic epithelial ceils on day 2 after castration (Fig. 
2a,b). Most of the immunopositive epithelial ceils were 
lining along the apical side of the epithelium. 
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Immunopositive apoptotic bodies were seen in some ultrastructural examination showed that many secretory 
parts of the epithelium on day 2 after the castration (Fig. vesicles were localized in apical cytoplasm and around 
2c). No immunopositive reaction was detected in Golgi areas in the normal prostate epithelium (Fig. 3a). 
sections obtained from uncastrated rats and However, no immunopositive epithelial cells were 
immunocontrol sections (data not shown). detected by the Fas-immunogold labeling method (Fig. 
3a, inset). Early ultrastructural changes of the epithelial 
lmmunogold method cells after castration were found to be temporarily 
dilated cisternae of endoplasmic reticulum on day 1 after 
As reported before (Kerr and Searle, 1973), pure the castration, which were later followed by progressive 
Flg. 1. Light micrographs of Fas immunolocalization by the 
immunoperoxidase technique (a, control; b, day 2; c, day 4) and 
by confocal laser scanning microscopy (d, day 2; e, day 4). 
a. No immunoreaction product is detected in normal prostates. b 
and d. immunoreaction products of Fas are mostly detected in 
granular patterns (small arrows) at apical sites of the prostate 
epithelium. They are also detected around supranuclear regions 
(large arrows). c and e. lmmunoreaction products are 
distributed throughout the cytoplasm (large arrows) and also in 
acinar lumens (c). M: interacinar tissue; L: 1umen.a-c, x 480; 
Inset, x 600. d. e, x 1,500 
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depletion of endoplasmic reticulum, a major cell 
organelle responsible for the protein synthesis. A slight 
increase in sizes of secretory vesicles was detected in 
conventional ultrathin sections on day 1 after the 
castration (Fig. 3b). Some secretory vesicles were 
immunolabeled by the Fas-immunogold method (Fig. 
3b7 inset), showing that secretory materials were 
immunopositive for Fas. Further immunoreaction 
products in secretory vesicles were apparently seen in 
other epithelial cells and localized around Golgi areas on 
day 1 (Fig. 3c7d). Pure ultrastructural examinations 
showed that epithelial cells on day 2 after the castration 
still contained many vesicles and Golgi areas (Fig. 4a,b). 
Immunogold particles for Fas were also found in the 
secretory vesicles (Fig. 4c), and appeared to be localized 
in both peripheral and central regions of the vesicles. 
Some immunogold particles were seen on outer surfaces 
of the epithelial cell membrane (Fig. 4c). 
On day 4, the reduction in height of epithelial cells 
was clearly detected (Fig. 5a), and secretory vesicles 
were apically localized in the epithelial cells. Some of 
them appeared to be fused to each other to form larger 
secretory vesicles, which were positively immunolabeled 
by the immunogold method (Fig. 5b, c), showing Fas 
localization in some epithelial cells on day 4 after the 
castration. 
Discussion 
In this study, we have reconfirmed that androgen 
ablation causes a rapid atrophy of the epithelium, which 
is mnfined to the ventral prostate (Sanford et al., 1984; 
Banerjee et al., 1995). At an electron microsmpic level, 
the androgen ablation reduced both epithelial celi height 
and number of apical vesicles containing secretory 
materials at later stages of day 4 and 5, but at an early 
stage of day 2, the epithelial ceiis showed an increased 
number of vesicles around Golgi areas and at apical 
cytoplasmic regions. In normal rats, the cell number in 
prostate ventral lobes is regulated by cell proliferation 
and apoptosis (Leach, 1998). Most of the columnar 
epithelial ceils, making up 80-85% of the ventral lobe, 
are dependent on androgenic steroids, and so this 
accounts for their response to androgen-withdrawal 
(English et al., 1987). It is also reported that the collapse 
and loss of endoplasmic reticulum are most prominent in 
epithelial mlls of prostate glands at late stages after the 
castration. The numbers of ribosomes and mitochondria 
gradually decreased, depending on periods after the 
castration. Some secretory vesicles were apically 
concentrated in residual epithelial cells, as described 
before (Kerr and Searle, 1973). Our present 
ultrastructural features were almost similar to those 
reported before (Kerr and Searle, 1973; Sanford et al., 
1984; English et al., 1987; Banerjee et al., 1995; Leach, 
1998). 
We have already reported the Fas immuno- 
localization in cultured prostatic epithelial cells at 
different concentrations of testosterone (Furuya et al., 
2000). In the previous study, the Fas expression was seen 
Fig. 2. Electron micrographs of Fas immunolocalization in the epiihelium on day 2. as revealed by the pre-embedding immunoperoxidase technique. a 
and b. lmmunoreaction products are detected at apical secretory vesicles (small arrows) and Golgi areas (G, large arrows) in some epiihelial cells. 
Inset: Some parts of the sui-íace cell membrane are also immunolabeled (small arrows). c. Apoptotic bodies are also immunoposithre in cytoplasm of 
another epithelial cell (large arrows). N: nucleus; L: lumen; G: Golgi area; E: endoplasmic reticulum; M: interaoinar matrix. Bar: 1 .O pm. x 5,000 
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under the culture condition of low dosage (10 nglml) of secretory vesicles in their apical cytoplasm. However, a 
testosterone. In the present study, the immunocyto- low arnoi.int of Fas was detected on the membrane surface 
chemieal analyses confirmed the Fas expression in the of some epithelial cells, as revealed by electron 
prostatic epithelial cells of castrated rats. Most of the microscopic immunocytochemistry. One probable reason 
irnmunostained epithelial cells contained various sizes of might be a technical limit of the post-embedding 
Fig. 3. a. Electron 
micrographs of prostate 
epithelial cells in 
normal uncastrated 
rats. Many vesicles are 
localized in apical 
cytopiasm (small 
arrows) and around 
Golgi areas (G, large 
anows). Inset: No 
speciñc immunogold 
labeling is detected in 
normal epithelial cells 
(large amws). N: 
Nucieus; G: Golgi area; 
E: endoplasmic 
reticulum; L: acinar 
lumen. Bar: 1 pm. 
x 5,000. M. Electron 
micrographs of prostate 
epkhelial cells on day 1 
after the castration. 
b: Apical secretory 
vesides are often seen 
(small arrows) and 
immundabeled with 
immunogold particles 
for Fas (Inset, large 
anows). Many small 
vesicies are Eocalized 
around Golgi areas (G, 
large arrows). Bar: 
1 pm. x 20,000. Inset: 
x 15,000. c: A Golgi 
area in supranuclear 
regions is also 
immunolabeled with 
immunogold particles 
for Fas. (G, large 
arrows). Small arrows 
indicate the 
immunogold labeling in 
aplcal secmtoy 
vesicies. Bar: 1 um. 
1 magnificationá the 
Golai area shom in 
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immunogold method. However, it is hardly accepted in the membrane Fas is localized along the vesicle membranes in 
present case, because many immunogold particles were comparison with the soluble Fas. 
actually seen inside secretory vesicles, as shown in Figures It was difficult to detect a clear relationship between 
3-5. Therefore, it is possible that a lower amount of the Fas-positive epithelial cells and apoptotic cells. The Fas 
and Fas immunogold 
labeling (c) of 
prostate epithelial 
cells on day 2 aíier 
castration. a and 
b. Some prostate 
epithelial cdls süll 
contain lots of cell 
organelles, including 
endoplmic 
reticulum (E), Golgi 
apparatus (G, large 
arrows) and 
secretory vesicles. 
[small arrows in (a) 
and large arrows in 
(b). c. Many 
immunogold 
particles Por Fas are 
sca'itered in wme 
secretory vesicles 
(large arrows), and 
also det- along 
the apical cell 
surface of epSthelial 
cells (small amws). 
L: acinar lumen; N: 
nucleus. a, x 7,000; 
b, x 20,000; 
c, x 25,000. 
Bar: 1 Hm. 
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in secretory vesicles seems not to be effective for 
inducing apoptosis, probably due to small amounts of 
the membrane Fas, as comparing a high percentage of 
the Fas-positive cells with the low percentage of 
apoptotic cells, as reported before (JSubo et al., 1998). If 
most of these vesicles contained large amounts of the 
membrane Fas, the number of apoptotic cells would be 
increased up to a similar percentage of the Fas- 
expressing epithelial cells. The present immunocyto- 
chemical data clearly indicate that Fas was localized 
mainly in secretory vesicles of the prostatic epithelium 
in castrated rats. Some previous studies have 
demonstrated that the prostatic epithelium expresses 
both Fas and Fas-ligand genes (Leithauser et al., 1993; 
French et al., 1996; Xerri et al., 1997), and an in vivo 
role of the Fas in the prostate was extensively studied by 
Suniki et al. (1996). They used lpr (Fas mutant) mice 
which expressed very low levels of Fas due to a genetic 
mutation. In their study, the prostatic apoptosis was 
induced in normal mice on day 2 following castration, 
though the prostates of the lpr mice showed no sign of 
apoptosis even at 20 days after the castration. Therefore, 
it is suggested that Fas-Fas ligand system is one of the 
major pathways for apoptosis in the prostate epithelium 
after the castration. Such an in vivo role of Fas for 
apoptosis in rat prostates was also supported by an 
experiment using ethane-1,2-dimethanesulfonate (EDS) 
to induce androgen ablation in rats (Ian et al., 1998). In 
the study, the regression in weight of the EDS-treated rat 
prostates was evident in a time-dependent manner, and 
Fas expression was also detected after the androgen 
ablation. In the above-mentioned reports, it should be 
notified that the "Fas" means a membrane Fas for 
inducing the apoptosis of prostatic epithelial cells, not a 
soluble Fas. In the present study, however, it is 
demonstrated that lots of soluble Fas appeared to be 
secreted from the prostate epithelial cells in comparison 
with the membrane Fas. 
Considering the appearance of the Fas-expressing 
cells and the apoptotic cells, our immunocytochemical 
data suggest two speculated mechanisms as follows. 
First, the Fas-expressing cells had potentiality for 
apoptosis, but they did not easily apoptose, because of 
relatively less amount of Fas-ligand in extracellular 
matrix. Second, if the Fas in secretory vesicles is almost 
soluble Fas, which is competitive against the membrane 
Fas for binding to Fas-ligand, the Fas-positive cells 
could survive in a manner of consuming the Fas-ligand. 
In other words, the soluble Fas-positive epithelíal cells 
mean a surviving cell population. The present 
immunocytochemical study clearly indicates that Fas 
was produced in secretory forms, probably soluble Fas, 
in prostate epithelial ceiis of castrated rats. 
Then it raised other important questions. The first 
question is whether soluble Fas in the vesicles plays a 
role as a receptor for the ceii death signal. As mentioned 
above, Fas in the prostate epithelial cells can be 
produced in both types, such as a cell-surface protein 
and a soluble one. In the two different forms, the Fas can 
not only mediate the apoptotic signal upon binding with 
Fas-ligand, but also block the apoptosis through 
competitive binding with Fas-ligand, as discussed before 
(Papoff et al., 1996). In humans, the soluble Fas is 
reported to be elevated in serum of the patients with 
malignancies, indicating that it is synthesized and 
released from the tumor cells to protect themselves from 
Hg. 5. Electron rnicrographs (a) and Fas irnrnunogold labeling (b, c) of prostate epithelial cells on day 4 after castration. a. Many fewer cell organelles 
are seen in almost al1 epithelial cells. Anows indicate secretory vesides. Apoptotic bodies are also seen in an epithelial cell (right bottorn). N: nucleus; 
O: Golgi apparatus; E: endoplasrnic retlculurn; L: acinar lurnen; M: interacinar rnatrix. x 4,000. Bar: 0.5 prn. b and c. Sorne secretory vesicles are still 
labeled with imrnunogold partides for Fas (arrows). L: acinar lurnen. b, x 30,000; c, x 50,000. Bar: 0.5 pm. 
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immune reactions (Lee et al., 1998). It was already 
reported that the soluble Fas also existed in rats 
(Kobayashi and Koike, 1996; Kimura et al., 1994). 
When the Fas-immunopositive secretory vesicles in the 
epithelial cells as seen in the present study contained lots 
of soluble Fas as described before, neutralization of Fas- 
ligand with the soluble Fas would inhibit triggering their 
apoptosis. So the soluble Fas-expressing cells may 
survive under the apoptotic conditions in comparison 
with Fas-negative cells. The second question is where 
Fas-ligand can be produced in the rat prostate. In this 
study, we could not yet detect Fas-ligand immuno- 
positive cells in rat prostate tissues. It is speculated that 
relatively low amounts of Fas-ligand were consumed in 
the epithelium of castrated rat prostates for surviving 
under the condition of androgen ablation. 
The last question is whether Fas-positive epithelial 
cells could apoptose immediately after the expression of 
Fas in their cytoplasm. As mentioned above, Fas- 
expressing epithelial cells were found to be more than a 
half of the whole prostate epithelium on day 2 after 
castration, as shown in Figure lb .  If al1 of the Fas- 
irnmunopositive cells immediately induce their apoptotic 
changes, they must disappear later. However, the rate of 
apoptosis in the epithelial cells was reported to be only 
about 10% at a peak under the similar experimental 
condition, as reported before (Kubo et al., 1998). Other 
investigators also reported that the prostate epithelial 
cells contained extremely high levels of Bcl-2 to survive 
after the castration, as compared with those in intact 
normal rats (McDonnell et al., 1992; Perlman et al., 
1999). Therefore, some residual epithelial cells may 
survive in the apoptotic microenvironment, because of 
protective functions of Bcl-2, though other Fas-positive 
cells may express low levels of Bcl-2, resulting in 
apoptosis. It will be necessary to perform other 
biochemical, immunological or genetic confirmation of 
both soluble Fas and membrane Fas, Bcl-2 and Fas- 
ligand in the prostate tissues after castration, including 
their immunohistochemical examination. 
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